What is the clinical evidence from this study?

Study design: Case Report. Population: Calcified Amorphous Tumor (CAT) (n=1). Intervention: Conservative management.

What does this research mean for the field?

Calcified Amorphous Tumor (CAT) is a rare, benign cardiac mass whose accurate echocardiographic differentiation from other masses like endocarditis is crucial for assessing embolic risk and guiding treatment. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To describe the clinical presentation, echocardiographic diagnosis, and conservative therapeutic management of a rare calcified amorphous tumor associated with mitral annular calcification.

September 15, 2026European Heart Journal Supplements

High surgical risk prompts conservative management of a rare calcified amorphous tumor linked to MAC.

View Full Paper

Ask AI

Bookmark

Population

One 77-year-old male with acute decompensated heart failure and a cardiac mass

Design

Case report

Key result

A 77-year-old male with multiple comorbidities was diagnosed with a rare Calcified Amorphous Tumor associated with mitral annular calcification and managed conservatively due to high surgical risk.

Authors

SLS Luciani ICI Capodaglio FPF Patani

Discussion

Member takes

Overview

May support conservative management in high-risk CAT with mitral annular calcification; leaves open need for larger outcome studies.

Key Points

To describe the clinical presentation, echocardiographic diagnosis, and conservative therapeutic management of a rare calcified amorphous tumor associated with mitral annular calcification.
Evaluated a 77-year-old male presenting with acute decompensated heart failure, ischemic heart disease, and moderate chronic kidney disease (N=1).
Performed transthoracic and transesophageal echocardiography along with coronary angiography to evaluate the intracardiac mass and coronary anatomy.
Echocardiography revealed a mobile, hyperechogenic intracavitary mass (15 mm × 3 mm) originating from the calcified posterior mitral annulus, alongside mild mitral stenosis and regurgitation.
High surgical risk led to a conservative management strategy for the cardiac tumor coupled with percutaneous coronary intervention and optimized heart failure medical therapy.

Study Design

Type

Case Report (n=1)

Structured PICO

Population

A 77-year-old male with chronic ischemic heart disease, prior CABG, HFrEF, T2DM, and moderate CKD presenting with acute decompensated heart failure and found to have a Calcified Amorphous Tumor.

Exposure

Percutaneous coronary intervention and conservative management of the MAC-CAT lesion, alongside optimized diuretic and guideline-directed heart failure therapy.

Echocardiography is crucial for the differential diagnosis of rare cardiac masses like Calcified Amorphous Tumor (CAT) to assess embolic risk and guide appropriate management.

Cite This Study

Luciani et al. (2026) conducted a case report in Calcified Amorphous Tumor (CAT) (n=1). Conservative management was evaluated. A 77-year-old male with multiple comorbidities was diagnosed with a rare Calcified Amorphous Tumor associated with mitral annular calcification and managed conservatively due to high surgical risk.

synapsesocial.com/papers/6aa90187eed42882c1fc19f8 https://doi.org/10.1093/eurheartjsupp/suag058.297

View Full Paper

Ask AI

Bookmark

September 15, 2026European Heart Journal Supplements

High surgical risk prompts conservative management of a rare calcified amorphous tumor linked to MAC.

View Full Paper

Ask AI

Bookmark

Population

One 77-year-old male with acute decompensated heart failure and a cardiac mass

Design

Case report

Key result

A 77-year-old male with multiple comorbidities was diagnosed with a rare Calcified Amorphous Tumor associated with mitral annular calcification and managed conservatively due to high surgical risk.

Authors

SLS Luciani ICI Capodaglio FPF Patani

Discussion

Member takes

Overview

May support conservative management in high-risk CAT with mitral annular calcification; leaves open need for larger outcome studies.

Key Points

To describe the clinical presentation, echocardiographic diagnosis, and conservative therapeutic management of a rare calcified amorphous tumor associated with mitral annular calcification.
Evaluated a 77-year-old male presenting with acute decompensated heart failure, ischemic heart disease, and moderate chronic kidney disease (N=1).
Performed transthoracic and transesophageal echocardiography along with coronary angiography to evaluate the intracardiac mass and coronary anatomy.
Echocardiography revealed a mobile, hyperechogenic intracavitary mass (15 mm × 3 mm) originating from the calcified posterior mitral annulus, alongside mild mitral stenosis and regurgitation.
High surgical risk led to a conservative management strategy for the cardiac tumor coupled with percutaneous coronary intervention and optimized heart failure medical therapy.

Study Design

Type

Case Report (n=1)

Structured PICO

Population

A 77-year-old male with chronic ischemic heart disease, prior CABG, HFrEF, T2DM, and moderate CKD presenting with acute decompensated heart failure and found to have a Calcified Amorphous Tumor.

Exposure

Percutaneous coronary intervention and conservative management of the MAC-CAT lesion, alongside optimized diuretic and guideline-directed heart failure therapy.

Echocardiography is crucial for the differential diagnosis of rare cardiac masses like Calcified Amorphous Tumor (CAT) to assess embolic risk and guide appropriate management.

Cite This Study

synapsesocial.com/papers/6aa90187eed42882c1fc19f8 https://doi.org/10.1093/eurheartjsupp/suag058.297

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark